-
Electronic (PDF)
-
Site License
-
Enterprisewide
Hypopharynx Cancer - Pipeline Review, Q4 2010
Global Markets Direct, December 2010, Pages: 27
Hypopharynx Cancer - Pipeline Review, Q4 2010
Summary
Global Markets Direct’s, “Hypopharynx Cancer Pipeline Review, Q4 2010”, provides an overview of the Hypopharynx Cancer therapeutic pipeline. This report provides information on the therapeutic development for Hypopharynx Cancer , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypopharynx Cancer . “Hypopharynx Cancer -Pipeline Review 2010, Q4 2010” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- A snapshot of the global therapeutic scenario for Hypopharynx Cancer .
- A review of the Hypopharynx Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Hypopharynx Cancer pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- A snapshot of the global therapeutic scenario for Hypopharynx Cancer .
- A review of the Hypopharynx Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Hypopharynx Cancer pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hypopharynx Cancer Overview
An Overview of Pipeline Products for Hypopharynx Cancer
Hypopharynx Cancer Therapeutics under Development by Companies
Hypopharynx Cancer Therapeutics under Investigation by Universities/Institutes
Companies Involved in Hypopharynx Cancer Therapeutics Development
Universities/Institutes Involved in Hypopharynx Cancer Therapeutics Development
Hypopharynx Cancer Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles – Universities/Institutes
Cisplatin + Fluorouracil + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Panitumumab + Cisplatin + Fluorouracil + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Radiation Therapy + Cetuximab - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
